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Electroacupuncture for postoperative pain
and gastrointestinal motility after laparoscopic




Background: Acupuncture is a widely serviced complementary medicine. Although acupuncture is suggested for
managing postoperative ileus and pain, supporting evidence is weak. The AcuLap trial is designed to provide
high-level evidence regarding whether or not electroacupuncture is effective in promoting gastrointestinal motility
and controlling pain after laparoscopic surgery.
Methods/design: This study is a prospective randomized controlled trial with a three-arm, parallel-group structure
evaluating the efficacy of electroacupuncture for gastrointestinal motility and postoperative pain after laparoscopic
appendectomy. Patients with appendicitis undergoing laparoscopic surgery are included and randomized into three
groups: 1) electroacupuncture group, 2) sham acupuncture group, and 3) control group. Patients receive 1) acupuncture
with electrostimulation or 2) fake electroacupuncture with sham device twice a day or 3) no acupuncture after
laparoscopic appendectomy. The primary outcome is time to first passing flatus after operation. Secondary outcomes
include postoperative pain, analgesics, nausea/vomiting, bowel motility, time to tolerable diet, complications, hospital
stay, readmission rates, time to recovery, quality of life, medical costs, and protocol failure rate. Patients and hospital staff
(physicians and nurses) are blinded to which group the patient is assigned, electroacupuncture or sham acupuncture.
Data analysis personnel are blinded to group assignment among all three groups. Estimated sample size to detect a
minimum difference of time to first flatus with 80 % power, 5 % significance, and 10 % drop rate is 29 × 3 groups = 87
patients. Analysis will be performed according to the intention-to-treat principle.
Discussion: The AcuLap trial will provide evidence on the merits and/or demerits of electroacupuncture for bowel
motility recovery and pain relief after laparoscopic appendectomy.
Trial registration: The trial was registered in Clinical Research Information Service (CRiS), Republic of Korea (KCT0001486)
on 14 May 2015.
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Background
With advances in surgery, Enhanced Recovery After
Surgery (ERAS) programs enable faster recovery after
surgery. The theoretical background of an ERAS pro-
gram is that minimizing pain and stress in patients
undergoing surgery prevents organ dysfunction and
complications and consequently enhances faster re-
covery. The clinical significance of ERAS programs has
been proven via many clinical studies. Early enteral feed-
ing with fast bowel motility recovery, and resultant fast
recovery and shortened hospital stay are advantages of
ERAS programs [1–7].
The key elements of an ERAS program include 1) pa-
tient information, 2) preservation of gastrointestinal func-
tion, 3) minimization of organ dysfunction, 4) active pain
control, and 5) promotion of patient autonomy [8, 9].
Many surgery centers are adopting ERAS programs and
trying to enhance recovery of surgical patients by means
of preserving gastrointestinal function and adequately
controlling postoperative pain.
Meanwhile, we searched the literature to find other
factors for recovery of surgical patients, and the litera-
ture review revealed that electroacupuncture might have
positive effects on postoperative bowel motility recovery
and pain control [10, 11]. Accordingly, we assumed that
electroacupuncture, which is not included in existing
ERAS programs, could accelerate recovery after surgery
by means of postoperative pain control and faster bowel
motility recovery.
This study aims to evaluate the postoperative effect of
electroacupuncture on bowel motility recovery and pain
relief in patients undergoing laparoscopic appendectomy.
Methods/design
Trial design
The AcuLap trial is a single-center, prospective random-
ized controlled trial with a three-arm, parallel-group de-
sign (Fig. 1). Data analysis will be performed according
to the intention-to-treat principle.
Methods: participants, interventions, and outcomes
Patients diagnosed with appendicitis and undergoing
laparoscopic appendectomy at Dongguk University
Gyeongju Hospital will be recruited.
Eligibility criteria
Patient screening
1. History taking and physical examination
2. Laboratory test including CBC (complete blood
count), CRP (C-reactive protein), serum chemistry,
and urinalysis
3. Radiologic test including abdominal X-ray and CT
(computed tomography) scan or ultrasonography.
Inclusion criteria
Inclusion criteria include the following:
1. Patients diagnosed with appendicitis
2. Patients over 20 years old
3. Patients undergoing laparoscopic appendectomy
Exclusion criteria
Exclusion criteria include the following:
1. Patients who need simultaneous combined surgery
(including ileocecectomy)
2. Patients diagnosed with combined other diseases as
well as appendicitis, preoperatively or
intraoperatively (such as colonic diverticulitis,
inflammatory bowel disease, and pelvic
inflammatory disease)
3. Patients who need postoperative fasting according
to preoperative evaluation or intraoperative findings
(for example, panperitonitis with intraperitoneal
abscess)
4. Patients under treatment for acute disease other
than appendicitis
5. Patients converted to open surgery
6. Patients with cardiac pacemaker
7. Patients with allergy to or phobia of acupuncture
needle or electrostimulation
8. Patients with history of syncope or seizure
9. Pregnant women or lactating women
10.Patients with history of abdominal surgery
11.Patients with American Society of Anesthesiologists
(ASA) physical status classification IV
12.Patients who do not consent to clinical trial
13.Patients incapable of reading, understanding, and
signing a written consent form (for example,
people who are mentally retarded, blinded,
illiterate, or foreigners)
14.Inmates of a prison or institution/hospital
Participating center/physicians
The study will be conducted in the Department of
Surgery, Dongguk University Gyeongju Hospital, Korea.
Laparoscopic appendectomy will be performed by
three board certified surgeons with minimum experience
of 8 years.
Acupuncture will be performed by two board certified




Patients with appendicitis undergoing laparoscopic sur-
gery are included and randomized into three groups: 1)
electroacupuncture group, 2) sham acupuncture group,
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and 3) no acupuncture group. Patient allocation is per-
formed by block randomization.
After laparoscopic appendectomy, routine postoperative
care is equally given to all patients except for interventions
(electroacupuncture or sham acupuncture). Clinical out-
comes including postoperative pain score and bowel
motility recovery are evaluated in each of the three groups
during hospitalization. Quality of life and medical cost are
evaluated after discharge.
Intervention group I: true electroacupuncture
Patients in the electroacupuncture group receive acu-
puncture with electrostimulation with stainless steel nee-
dles and a PG-306 electroacupuncture device after the
operation. At least 2 hours after the operation,
electroacupuncture is given for 30 minutes, twice a day,
with a minimum interval of 4 hours between the morn-
ing session and afternoon session, starting on operation
day. A maximum of four acupuncture treatments are per-
formed during hospitalization. This acupuncture schedule
is set from the literature review [12] and in consideration
of the usual hospital stay after laparoscopic appendectomy.
Acupuncture is performed by Korean board certified
oriental medicine doctors with 10 years of experience in
acupuncture. Acupuncture sites (locations) are the fol-
lowing which are known to control pain and promote
gastrointestinal motility: LI4 (Hapgok, Hegu), PC6
(Naegwan, Neiguan), KI6 (Johae, Zhaohai), and LR3
(Taechung, Taichong). Those acupoints are selected be-
cause they are well-known meridians for treating
Fig. 1 AcuLap trial flowchart
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gastrointestinal disorders including low abdominal pain
and are currently employed in our Korean oriental
medical clinic.
Patients, physicians, and nurses are blinded to which
intervention patients are allocated, electroacupuncture
versus sham acupuncture.
Intervention group II: sham electroacupuncture
Patients in the sham acupuncture group receive fake
electroacupuncture with a Park Sham Device (PSD). The
PSD is a device designed for sham acupuncture which
gives little stimulation but a fake sound. The PSD has a
PG-306 electric pulse generator, just as in the true acu-
puncture. However, in the PSD, the internal wire inside
PG-306 is cut so as not to deliver the electric pulse to
patients, and the patients only hear continuous sound
(fake sound) which resembles the electrostimulation.
Schedules for service and acupuncture sites are the
same as in the electroacupuncture group.
Patients, physicians, and nurses are blinded to which
intervention patients are allocated, electroacupuncture
versus sham acupuncture.
Control group
Patients in the control group receive routine standard
postoperative care without acupuncture.
Routine postoperative care for all participants
1. Routine NSAID (nonsteroidal anti-inflammatory
drug) injection for postoperative pain control every
8 hours/additional injection on patient’s request
2. Start sips of water after bowel sound is checked by
auscultation, unless patient complains of nausea or
vomiting
3. Start soft diet after sips of water when patient is able
to walk independently without nausea or vomiting
4. No patient controlled anesthesia (PCA)
Outcomes
Primary outcome
The primary outcome is time to first passing flatus after
operation.
Secondary outcomes
Secondary outcomes include postoperative pain, analge-
sics, nausea/vomiting, bowel motility, time to tolerable
diet, complications, hospital stay, readmission rates, time
to recovery, quality of life, medical costs, and protocol
failure rate.
Postoperative pain will be checked regularly three
times a day and will be recorded using the visual
analog scale.
Intravenous analgesic injections will be counted daily.
Nausea and vomiting will be counted daily.
Bowel motility will be checked regularly three times a
day, by attending surgeons. Bowel sound will be counted
in a minute by auscultation.
Postoperative complications will be checked according
to Accordion Severity Classification of Postoperative
Complications [13].
Time to recovery is defined as time to ambulate and
perform self-care by patient himself or herself.
Discharge is recommended when the patient meets
discharge criteria as follows:
1. Controllable pain with analgesics
2. No nausea/vomiting
3. Passing flatus or feces
4. Toleration of soft diet
5. Mobilization (independent walking) and self-care
6. Controlled complications less than moderate by
Accordion system (Table 1)
Quality of life will be assessed by SF-36 Health Survey
questionnaire [14], on first outpatient clinic visit.
Table 1 Accordion severity classification of postoperative complications: expanded classification [13]
1. Mild Requires only minor invasive procedures that can be done at the bedside such as insertion of intravenous lines,
urinary catheters, and nasogastric tubes, and drainage of wound infections. Physiotherapy and the following drugs
are allowed: antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy.
2. Moderate Requires pharmacologic treatment with drugs other than those allowed for minor complications, for instance,
antibiotics. Blood transfusions and total parenteral nutrition are also included.
3. Severe Invasive procedure without general anesthesia. Requires management by an endoscopic, interventional procedure
or re-operationa without general anesthesia.
4. Severe Operation under general anesthesia. Requires management by an operation under general anesthesia.
5. Severe Organ system failure.b
6. Death Postoperative death.
aAn example would be a wound re-exploration under conscious sedation and/or local anesthetic
bSuch complications would normally be managed in an increased acuity setting, but in some cases patients with complications of lower severity might also be
admitted to an ICU
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Participant timeline
Patient enrollment will be done before operation. After
eligibility screen, an informed consent will be obtained
at outpatient clinic, emergency department, or ward.
After enrollment, random allocation will be performed
using blocks. The interventions (electroacupuncture or
sham electroacupuncture) will be given twice a day after
operation, from operation day to postoperative day 2. All
clinical outcome variables will be assessed from oper-
ation day until discharge day; except for quality of life,
readmission, medical costs, and protocol failure, which
will be assessed on the first visit day (postoperative day
7) after discharge (Table 2).
Sample size/recruitment
The primary endpoint is time to first passing flatus,
which is defined as hours between end of operation and
first flatus after operation. To calculate the sample size, a
literature review was performed on acupuncture and its
effect on bowel motility after laparoscopic surgery. The
most similar study to this trial is that of Yu et al. [15].
They measured flatus time after laparoscopic cholecystec-
tomy in an electric acupuncture group (n = 30), analgesia-
pumper group (n = 30), and a control group (n = 30). The
flatus time was shorter in the electric acupuncture group
as compared with the other two groups [(14.77 ± 4.99)
hours versus (18.50 ± 4.22) hours, P < 0.01; (14.77 ± 4.99)
hours versus (18.17 ± 4.69) hours, P < 0.05].
For the AcuLap trial, the estimated number of partici-
pants to detect a minimum difference of time to first
flatus with 80 % power, 5 % significance, and 10 % drop
rate is 29 × 3 groups = 87 patients.
Methods: assignment of interventions
Allocation
Allocation sequence will be generated using block
randomization with StatsDirect 3 software by a random-
izing person at the study center. After obtaining an
Table 2 Time schedule of enrollment, interventions, and assessments
Study period
Enrollment Allocation Post-allocation Close-out






Electroacupuncture X X X
Sham electroacupuncture X X X
Control
Assessments:
Passing flatus X X X X X
Postoperative pain X X X X X
Analgesics X X X X X
Nausea/vomiting X X X X X
Bowel motility X X X X X
Tolerability to diet X X X X X
Complications X X X X X
Time to recovery X X X X X
Fulfillment of defined discharge criteria X X X X X
Patient’s agreement to discharge X X X X X




Protocol failure rate X
-t1, time before operation; t0, operation day; t1-tx, postoperative day 1 to postoperative day X (= actual discharge day); tx+1, the first visit day on outpatient clinic
after discharge
Kim Trials  (2015) 16:461 Page 5 of 8
informed consent from an eligible patient, the recruiter
will be given a treatment code assigned to the patient
from the centrally generated allocation sequence to
which access is restricted for the recruiter.
Blinding
Two of the treatment codes are electroacupuncture and
sham electroacupuncture; and the other code is control.
Patients, physicians/nurses, and data analyzers are
blinded between electroacupuncture and sham electroa-
cupuncture. Only oriental medicine doctors who perform
acupuncture know which treatment code corresponds to
which procedure between two interventions.
The control group cannot be blinded.
Methods: data collection, management, and analysis
Data collection methods
All data will be collected using the daily assessment
form and will be recorded in case record form, from op-
eration day to discharge day (Table 3). Postoperatively,
on the first visit to the outpatient clinic, a quality of life
questionnaire (SF-36) will be filled in by the patient.
Statistical methods
Analysis of primary outcome:
Median of first flatus time will be analyzed by the
Student’s t-test. P values less than 0.05 will be regarded
as statistically significant.
Analysis of secondary outcomes:
Categorical data will be analyzed by the chi-square
test or Fisher’s exact test. Continuous data will be
analyzed by the unpaired t-test or Wilcoxon’s rank
sum test. P values less than 0.05 will be regarded as
statistically significant.
Missing data less than 5 % of the sample will be
dropped. For missing data that amount to more than
5 %, analysis will be carried out with missing data imput-
ation by the last observation carried forward and the
maximum likelihood estimation method.
Ethics
This trial is conducted in accordance with the princi-
ples of the Declaration of Helsinki and good clinical
practice guidelines.
Research ethics approval
The independent medical ethics committee (Institutional
Review Board of Dongguk University Gyeongju Hospital,
Korea) has approved this trial (approval number: 110757-
201410-HR-04-04). The trial was registered on 14 May
2015 at Clinical Research Information Service (CRiS),
Republic of Korea (registration number: KCT0001486).
Consent/confidentiality
Attending surgeons will obtain written informed consent
from all trial participants before inclusion. All collected
data will be kept confidential at all times.
Table 3 Daily assessment form: from operation day to discharge day
Operation POD1 POD2 POD3 POD4 POD5 ……. Discharge




Nausea/vomiting Nausea: No/Yes(___/day) Vomiting: No/
Yes(___/day)
Bowel motility (bowel sound/minute) 1) Morning: __/min
2) Mid-day: __/min
3) Evening: __/min
Intestinal passage Flatus: Yes(___/day)/No
Stool: Yes(___/day)/No
Tolerability to liquid Yes/No
Tolerability to soft diet Yes/No
Mobilization and self-care Yes/No
Postoperative complications (Accordion
classification)
No/ 1/ 2/ 3/ 4/ 5
Fulfillment of defined discharge criteria ___/total(5)
Patient’s agreement to discharge Yes/No
VAS visual analogue scale, POD postoperative day
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Discussion
Garcia et al. reviewed 41 randomized controlled trials
(RCTs) evaluating the efficacy of acupuncture for symp-
tom management in patients with cancer [10]. Pain, nau-
sea, and postoperative ileus were the most commonly
studied symptoms. Among those RCTs, only one study,
by Shen et al. [16], showed a positive conclusion for
nausea with low risk of bias. For symptoms other than
nausea, the efficacy of acupuncture remained undeter-
mined because of the high risk of bias. Eleven RCTs on
pain [17–27], 10 RCTs on nausea [24, 28–36], and 8
RCTs on ileus [17, 18, 23, 37–41] were identified as hav-
ing high or unclear risk of bias and showed positive or
negative conclusions for each symptom.
From the literature review, we concluded that acu-
puncture needs to be studied with a more sophisticated
design to justify its unproven efficacy. The AcuLap trial
aims to evaluate the postoperative effect of electroacu-
puncture on bowel motility recovery and pain relief in
patients undergoing laparoscopic appendectomy. We an-
ticipate that the trial will provide high-level evidence on
the merits and/or demerits of electroacupuncture after
laparoscopic surgery.
The strength of this study lies in proving the true
effect of acupuncture on postoperative recovery by com-
paring patients receiving true acupuncture or sham acu-
puncture and a control group. If the true acupuncture
group shows a better outcome compared to the sham
group, the true effect of acupuncture can be justified on
postsurgical patients. However, if the true acupuncture
group fails to show a superior outcome to the sham
group, even though the acupuncture group shows better
recovery compared to the control group, a placebo effect
of acupuncture should be considered. This is the first
published protocol in English to investigate the efficacy
of acupuncture on postoperative pain and ileus after lap-
aroscopic appendectomy. We hope to share this protocol
with any investigators who are interested in acupuncture
and postsurgical recovery.
On the other hand, it is possible that the study may
not reveal statistically significant positive or negative
conclusions, because laparoscopic appendectomy is min-
imally invasive surgery, and most patients undergoing
laparoscopic appendectomy show fast recovery after sur-
gery. However, we hope to design our next study in
other surgical procedures using the experiences from
this study.
Trial status
The trial has been open for recruitment since June 2015.
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